SAB Biotherapeutics, Inc. (SABS)
Total Valuation
SABS has a market cap or net worth of $41.88 million. The enterprise value is $44.11 million.
Market Cap | 41.88M |
Enterprise Value | 44.11M |
Important Dates
The next estimated earnings date is Tuesday, May 14, 2024, before market open.
Earnings Date | May 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
SABS has 9.23 million shares outstanding. The number of shares has increased by 21.79% in one year.
Shares Outstanding | 9.23M |
Shares Change (YoY) | +21.79% |
Shares Change (QoQ) | +3.94% |
Owned by Insiders (%) | 19.03% |
Owned by Institutions (%) | 38.88% |
Float | 3.36M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 10.23 |
Forward PS | n/a |
PB Ratio | 2.75 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 10.77 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.34, with a Debt / Equity ratio of 0.30.
Current Ratio | 0.34 |
Quick Ratio | n/a |
Debt / Equity | 0.30 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -82.62 |
Financial Efficiency
Return on equity (ROE) is -120.40% and return on invested capital (ROIC) is -135.93%.
Return on Equity (ROE) | -120.40% |
Return on Assets (ROA) | -69.20% |
Return on Capital (ROIC) | -135.93% |
Revenue Per Employee | $73,122 |
Profits Per Employee | -$485,922 |
Employee Count | 56 |
Asset Turnover | 0.10 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, SABS has paid $25,629 in taxes.
Income Tax | 25,629 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +2.20% in the last 52 weeks. The beta is 0.79, so SABS's price volatility has been lower than the market average.
Beta (1Y) | 0.79 |
52-Week Price Change | +2.20% |
50-Day Moving Average | 5.35 |
200-Day Moving Average | 7.18 |
Relative Strength Index (RSI) | 41.63 |
Average Volume (30 Days) | 18,361 |
Short Selling Information
The latest short interest is 20,886, so 0.23% of the outstanding shares have been sold short.
Short Interest | 20,886 |
Short Previous Month | 24,545 |
Short % of Shares Out | 0.23% |
Short % of Float | 0.62% |
Short Ratio (days to cover) | 0.83 |
Income Statement
In the last 12 months, SABS had revenue of $4.09 million and -$27.21 million in losses. Loss per share was -$5.70.
Revenue | 4.09M |
Gross Profit | 4.09M |
Operating Income | -27.06M |
Pretax Income | -27.19M |
Net Income | -27.21M |
EBITDA | -23.14M |
EBIT | -26.86M |
Loss Per Share | -$5.70 |
Balance Sheet
The company has $2.43 million in cash and $4.65 million in debt, giving a net cash position of -$2.23 million or -$0.24 per share.
Cash & Cash Equivalents | 2.43M |
Total Debt | 4.65M |
Net Cash | -2.23M |
Net Cash Per Share | -$0.24 |
Equity / Book Value | 15.26M |
Book Value Per Share | 1.65 |
Working Capital | -6.08M |
Cash Flow
In the last 12 months, operating cash flow was -$11.46 million and capital expenditures -$202,594, giving a free cash flow of -$11.66 million.
Operating Cash Flow | -11.46M |
Capital Expenditures | -202,594 |
Free Cash Flow | -11.66M |
FCF Per Share | -$2.23 |
Margins
Gross margin is 100.00%, with operating and profit margins of -660.87% and -664.53%.
Gross Margin | 100.00% |
Operating Margin | -660.87% |
Pretax Margin | -663.91% |
Profit Margin | -664.53% |
EBITDA Margin | -565.01% |
EBIT Margin | -655.97% |
FCF Margin | -284.71% |
Dividends & Yields
SABS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -21.79% |
Shareholder Yield | -21.79% |
Earnings Yield | -64.97% |
FCF Yield | -27.84% |
Analyst Forecast
The average price target for SABS is $20.00, which is 334.78% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $20.00 |
Price Target Difference | 334.78% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on January 5, 2024. It was a reverse split with a ratio of 1:10.
Last Split Date | Jan 5, 2024 |
Split Type | Reverse |
Split Ratio | 1:10 |
Scores
SABS has an Altman Z-Score of -4.64 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -4.64 |
Piotroski F-Score | 2 |